Free Trial

Moleculin Biotech (MBRX) SEC Filings & 10K Form

Moleculin Biotech logo
$1.88 +0.14 (+8.05%)
Closing price 01/17/2025 04:00 PM Eastern
Extended Trading
$1.92 +0.05 (+2.39%)
As of 08:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Moleculin Biotech SEC Filings

DateFilerForm TypeView
01/08/2025
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:02 PM
Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/11/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
12/03/2024
4:20 PM
Moleculin Biotech (Filer)
Form POS AM
11/18/2024
7:20 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:20 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:35 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
4:09 PM
Moleculin Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:00 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:00 PM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM
Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM
CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM
George Robert E. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:04 PM
Climaco John M (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:05 PM
Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:06 PM
Moleculin Biotech (Issuer)
Yan Joy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:27 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:43 PM
Moleculin Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/25/2024
3:16 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:40 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
7:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
4:15 PM
Moleculin Biotech (Filer)
Form PRE 14A
08/19/2024
3:10 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
9:06 AM
Moleculin Biotech (Filer)
Form 424B3
08/16/2024
3:54 PM
Moleculin Biotech (Filer)
Form 424B4
08/15/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
08/15/2024
10:21 AM
Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
8:57 PM
Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
7:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
8:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:35 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
A simple pattern that works in any market (Ad)

Right when most traders were getting bearish, The All-Weather Pattern signaled something different. Following this setup could've turned every $1,000 into $1,770 in just 48 hours. But here's what really gets me excited... You don't need to be glued to your screen all day, no complex formulas, no guessing. Just wait for a stock to close below The All-Weather Pattern, then check if it opens higher the next morning. That's it. While of course I cannot promise future returns or against losses… I've put together a complete breakdown of how this works, including the new stock that’s tending towards The All-Weather Pattern this week.

If you’re interested, the complete details are all here.
07/30/2024
6:00 AM
Moleculin Biotech (Filer)
Form S-1/A
07/22/2024
4:31 PM
Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/10/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
4:01 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
06/25/2024
5:00 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:01 PM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:02 PM
Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:00 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:01 PM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:01 PM
Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
7:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:05 PM
Moleculin Biotech (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/16/2024
7:32 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:38 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:16 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:55 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
8:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
4:15 PM
Moleculin Biotech (Filer)
Form 10-K/A
04/25/2024
7:23 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
4:14 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
8:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
2:03 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
3:31 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
8:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
4:19 PM
Moleculin Biotech (Filer)
Form 424B3
02/15/2024
8:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:36 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:43 PM
ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
Form SC 13G
02/12/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
02/02/2024
4:05 PM
Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/24/2024
7:50 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MBRX) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners